Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Natural Killer cells and monoclonal antibodies: Two partners for successful antibody dependent cytotoxicity against tumor cells
Mélanie Gauthier, Caroline Laroye, Danièle Bensoussan, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 160, pp. 103261-103261
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Leveraging NKG2D Ligands in Immuno-Oncology
Mercedes B. Fuertes, Carolina I. Domaica, Norberto W. Zwirner
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 95
From CAR-T Cells to CAR-NK Cells: A Developing Immunotherapy Method for Hematological Malignancies
Hui Lü, Xiaoyan Zhao, Ziying Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 89
Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia
Zonghan Wang, Wei Li, Hao Dong, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 13
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting
Kristin M. Snyder, Kate Dixon, Zachary Davis, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 12, pp. e007280-e007280
Open Access | Times Cited: 13
Avelumab induces greater Fc-Fc receptor-dependent natural killer cell activation and dendritic cell crosstalk compared to durvalumab
Nicole Osborne, Amit Rupani, Vladimir Makarov, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
Examination of IgG Fc Receptor CD16A and CD64 Expression by Canine Leukocytes and Their ADCC Activity in Engineered NK Cells
Robert Hullsiek, Yunfang Li, Kristin M. Snyder, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Ocrelizumab Alters Cytotoxic Lymphocyte Function While Reducing EBV-Specific CD8 + T-Cell Proliferation in Patients With Multiple Sclerosis
Gianmarco Abbadessa, Maria Teresa Lepore, Sara Bruzzaniti, et al.
Neurology Neuroimmunology & Neuroinflammation (2024) Vol. 11, Iss. 4
Open Access | Times Cited: 3
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications
Paolo Sportoletti, Filomena De Falco, Beatrice Del Papa, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6665-6665
Open Access | Times Cited: 19
Biomimetic nanoparticles for tumor immunotherapy
Hanqing Yu, Meng–Huang Wu, Siyu Chen, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 14
The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC
Eliza Guti, Zsolt Regdon, Isotta Sturniolo, et al.
Cancer Immunology Immunotherapy (2022) Vol. 71, Iss. 9, pp. 2151-2168
Open Access | Times Cited: 12
Soluble and insoluble expression of recombinant human interleukin-2 protein using pET expression vector in Escherichia coli
Atif Ahmed, Nao Akusa Fujimura, Saad Tahir, et al.
Preparative Biochemistry & Biotechnology (2024) Vol. 55, Iss. 1, pp. 45-57
Closed Access | Times Cited: 2
Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity
Ying Gong, Roel G. J. Klein Wolterink, Valeriia Gulaia, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2579-2579
Open Access | Times Cited: 16
The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology
Florencia Secchiari, Sol Yanel Núñez, Jessica Mariel Sierra, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 11
Driving natural killer cell-based cancer immunotherapy for cancer treatment: An arduous journey to promising ground
Dandan Jiang, Jingya Zhang, Zhenkun Mao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115004-115004
Open Access | Times Cited: 5
Advancing Cancer Therapy: A Review of Recent Progress in Monoclonal Antibodies
Buddadasari Snehitha, Mopuri Jyothsna, A Sai, et al.
Asian Journal of Advances in Research (2024) Vol. 7, Iss. 1, pp. 159-173
Open Access | Times Cited: 1
iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma
Kate Dixon, Kristin M. Snyder, Melissa Khaw, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
The Dual Role of Innate Lymphoid and Natural Killer Cells in Cancer. from Phenotype to Single-Cell Transcriptomics, Functions and Clinical Uses
Stefania Roma, Laura Carpen, Alessandro Raveane, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5042-5042
Open Access | Times Cited: 9
Killers on the loose: Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatment
Cordelia Dunai, Erik Ames, María C. Ochoa, et al.
International review of cell and molecular biology (2022), pp. 65-122
Closed Access | Times Cited: 5
Advances in immune therapies in hematological malignancies
Luca Mazzarella, Gunilla Enblad, Johanna Olweus, et al.
Journal of Internal Medicine (2021) Vol. 292, Iss. 2, pp. 205-220
Open Access | Times Cited: 6
NK92 Expressing anti-BCMA CAR and Secreted TRAIL: a Promising Combination Treatment against Multiple Myeloma
Benjamin Motais, Sandra Charvátová, Zuzana Walek, et al.
(2023)
Open Access | Times Cited: 2
Monoclonal War: The Antibody Arsenal and Targets for Expanded Application
Eric H. Rosenn, Mickael Benhaim, Allison Siegel, et al.
Immuno (2023) Vol. 3, Iss. 3, pp. 346-357
Open Access | Times Cited: 2
Transcriptomic analysis of spleen B cell revealed the molecular basis of bursopentin on B cell differentiation
Ze Zhang, Jiaxi Cai, Shanshan Hao, et al.
Veterinary Research (2022) Vol. 53, Iss. 1
Open Access | Times Cited: 3
Ammonia inhibits antitumor activity of NK cells by decreasing mature perforin
J Domagała, Tomasz M. Grzywa, Iwona Baranowska, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
NK92 Expressing Anti-BCMA CAR and Secreted TRAIL for the Treatment of Multiple Myeloma: Preliminary In Vitro Assessment
Benjamin Motais, Sandra Charvátová, Zuzana Walek, et al.
Cells (2023) Vol. 12, Iss. 23, pp. 2748-2748
Open Access | Times Cited: 1
Impairment of NK Cell Mediated Immune Surveillance Against Acute Myeloid Leukemia
M.D. RAGHDAA M. ALI WAEL S. TAHA
Turkish Journal of Oncology (2022)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top